Page last updated: 2024-08-25

bexarotene and Idiopathic Parkinson Disease

bexarotene has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burstein, ES; Hubbard, D; Ma, JN; McFarland, K; Olsson, R; Spalding, TA	1

Other Studies

1 other study(ies) available for bexarotene and Idiopathic Parkinson Disease

Article	Year
Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease. ACS chemical neuroscience, 2013, Nov-20, Volume: 4, Issue:11 Topics: Administration, Oral; Animals; Behavior, Animal; Bexarotene; Bioluminescence Resonance Energy Transfer Techniques; Cell Survival; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Infusions, Subcutaneous; Injections, Intraventricular; Male; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Primary Cell Culture; Protein Multimerization; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes	2013

Article

Year

Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease.

ACS chemical neuroscience, 2013, Nov-20, Volume: 4, Issue:11

Topics: Administration, Oral; Animals; Behavior, Animal; Bexarotene; Bioluminescence Resonance Energy Transfer Techniques; Cell Survival; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Infusions, Subcutaneous; Injections, Intraventricular; Male; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Primary Cell Culture; Protein Multimerization; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes

2013